An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background-Reference-Cited by-同舟云学术

An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background

Published:2012-10-31 Issue:7424 Volume:491 Page:449-453
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Mitra Devarati,Luo Xi,Morgan Ann,Wang Jin,Hoang Mai P.,Lo Jennifer,Guerrero Candace R.,Lennerz Jochen K.,Mihm Martin C.,Wargo Jennifer A.,Robinson Kathleen C.,Devi Suprabha P.,Vanover Jillian C.,D’Orazio John A.,McMahon Martin,Bosenberg Marcus W.,Haigis Kevin M.,Haber Daniel A.,Wang Yinsheng,Fisher David E.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature11624.pdf

Reference30 articles.

1. Rhodes, A. R., Weinstock, M. A., Fitzpatrick, T. B., Mihm, M. C. J. & Sober, A. J. Risk factors for cutaneous melanoma. A practical method of recognizing predisposed individuals. J. Am. Med. Assoc. 258, 3146–3154 (1987)

2. Valverde, P., Healy, E., Jackson, I., Rees, J. L. & Thody, A. J. Variants of the melanocyte-stimulating hormone receptor gene are associated with red hair and fair skin in humans. Nature Genet. 11, 328–330 (1995)

3. Rouzaud, F., Kadekaro, A. L., Abdel-Malek, Z. A. & Hearing, V. J. MC1R and the response of melanocytes to ultraviolet radiation. Mutat. Res. 571, 133–152 (2005)

4. Wenczl, E. et al. (Pheo)melanin photosensitizes UVA-induced DNA damage in cultured human melanocytes. J. Invest. Dermatol. 111, 678–682 (1998)

5. Hill, H. Z. & Hill, G. J. UVA, pheomelanin and the carcinogenesis of melanoma. Pigment Cell Res. 13 (suppl. 8). 140–144 (2000)

Cited by 406 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MITF regulates IDH1, NNT, and a transcriptional program protecting melanoma from reactive oxygen species;Scientific Reports;2024-09-14

2. Survival in uveal melanoma patients is linked to genetic variation at HERC2 SNP rs12913832;Ophthalmology;2024-09

3. Advances in GPCR-targeted drug development in dermatology;Trends in Pharmacological Sciences;2024-08

4. An overview of benefits and risks of chronic melanocortin‐1 receptor activation;Journal of the European Academy of Dermatology and Venereology;2024-07-31

5. An Update on New and Existing Treatments for the Management of Melasma;American Journal of Clinical Dermatology;2024-06-19